Biomerica, Inc.

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are use…

Medical - Devices

US, Irvine [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Major Shareholders · Proxy Ben. Owners

Shareholders

Major Shareholders · Structure

Breakdown

The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Biomerica, Inc.

Biomerica, Inc. can't present any analysts estimates at the moment detail analysis.

Intraday

Shares Outstanding

16,821,600

Volume

371,942

Volume on Avg.

952,850

Beneficial Owners Beta

Beneficial owners who control a significant portion of the shares outstanding.

SEC Source

Form 3/4/5

Owner	Shares	Equivalence - $0.35 per share	Last Form/Filing	Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
Emerson Jane Internal : Director	0	$0	12/11/20	0 x $0 = $0
Irani Zackary S. Internal : Chief Executive Officer	1,017,360	$356,076.00	05/05/23	P 1,000 x $1.36 = $1,360.00
Moatazedi David Internal : Director	0	$0	12/11/23	0 x $0 = $0
Barbieri Allen Internal : Executive Vice Chairman	107,289	$37,551.15	06/24/22	G 7,500 x $0 = $0
Lu Gary Internal : Chief Financial Officer	155,000	$54,250.00	12/17/24	A 155,000 x $0.31 = $48,050.00
Coste Catherine Internal : Director	0	$0	12/11/23	0 x $0 = $0
Kenny John P. Internal : Director	0	$0	12/11/23	0 x $0 = $0
Sloan Steven Internal : Chief Financial Officer	0	$0	12/10/21	0 x $0 = $0
Sirgo Mark A Internal : Director	0	$0	12/10/21	0 x $0 = $0
Cano Francis Internal : Director	146,736	$51,357.60	12/11/20	G 20,000 x $0 = $0